JP Patent

JP5311825B2 — ２−イミダゾリン構造を有するα−交感神経興奮薬の新規な使用

Assigned to Merck Patent GmbH · Expires 2013-10-09 · 13y expired

What this patent protects

Patent listed against Veklury.

Drugs covered by this patent

Patent Metadata

Patent number
JP5311825B2
Jurisdiction
JP
Classification
—
Expires
2013-10-09
Drug substance claim
No
Drug product claim
No
Assignee
Merck Patent GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.